Managing Non-cancer Pain: The Most Recent Evidence on Effective, Safe Strategies Post-test

Topical NSAIDs may be effective at relieving pain and improving function in patients with osteoarthritis of the knee and contraindications to systemic NSAIDs.*
- True
- False
Which of the following statements best describes non-pharmacologic management of osteoarthritis?*
- Staying active with exercise and movement-based activities, like physical therapy or tai chi, are effective for reducing pain and improving function.
- Self-management education classes offer a large effect on pain or function in patients with osteoarthritis.
- Mindfulness meditation has strong evidence that shows a reduction in pain intensity.
- Weight loss has no role in reducing pain in patients with osteoarthritis who are overweight.
Regarding the treatment of low back pain, which statement is true?*
- Topical NSAIDs are equally effective as systemic NSAIDs.
- Tramadol or buprenorphine have no role in patients without a treatment response to other effective options.
- Yoga and CBT are effective non-pharmacologic options for managing low back pain.
- Tricyclic antidepressants are effective and well-tolerated by the elderly.
Regarding the treatment of diabetic neuropathy, which statement is true?*
- NSAIDs work well in reducing pain.
- Opioids, like oxycodone, are effective for long-term pain control.
- Non-pharmacologic options like yoga are the backbone of treatment.
- Duloxetine and pregabalin are similarly effective at reducing pain.
Which of the following statements is true regarding managing fibromyalgia?*
- Exercise and maintaining a healthy weight can help patients manage fibromyalgia.
- Duloxetine is the only effective pharmacologic option for the treatment of fibromyalgia.
- A transcutaneous electrical nerve stimulation device is an effective option for treating fibromyalgia.
- Due to the nature of fibromyalgia, non-pharmacologic therapies have no role in treatment.
Pain management plans _________________________.*
- identify the quantity of pills that will be prescribed each month.
- establish functional goals and clear expectations of pain treatment.
- focus on complete pain relief.
- provide a reason to terminate patients from your practice.
Which of the following statements is true regarding the management of patients prescribed opioids?*
- The benefits of opioid therapy should outweigh the risks.
- Opioid doses above 90 MME per day must be decreased immediately.
- Naloxone has no role for older patients on stable doses of opioids.
- Toxicology testing should be obtained at every visit.
Which of the following statements is true regarding buprenorphine for pain?*
- No DEA license is required in order to prescribe transdermal or buccal buprenorphine.
- The risk of overdose is lower due to a ceiling effect on respiratory depression compared to other opioids.
- Buprenorphine has a ceiling effect for pain response and so is not an effective medication for pain.
- Buprenorphine is an opioid and has no role in pain management.
Which of the following statements is true regarding tapering prescribed opioids?*
- A clinic-based, one-size-fits-all approach to opioid dose reduction is best.
- All patients with tolerance and physiologic dependence on opioids will have significant withdrawal symptoms requiring medication support while continuing to reduce the opioid dose.
- Reassuring the patient that you will support them through the taper has no effect on tapering.
- Provide new options to manage pain when reducing an opioid dose.
Which of the following statements is true regarding prescribing opioids for acute pain?*
- Non-opioid medications are significantly less effective than opioids
- Prescribing opioids beyond 30 days may lead to long-term use.
- Extended-release/long-acting opioids provide the better acute pain control compared to immediate release opioids.
- Opioids for acute pain should be taken on a regular schedule for the first three days.

Managing Non-cancer Pain: The Most Recent Evidence on Effective, Safe Strategies Post-test

Step 1 of 2

Join our newsletter